Compounds > adenosine diphosphate
Page last updated: 2024-08-17

adenosine diphosphate and valsartan

adenosine diphosphate has been researched along with valsartan in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Casado, S; Farré, J; Gómez, J; Jiménez, A; López-Blaya, A; López-Farré, A; Montón, M; Núñez, A; Sánchez de Miguel, L; Zalba, LR1
Casado, S; Gómez, J; Jiménez, A; López-Blaya, A; López-Farré, A; Montón, M; Núñez, A; Uriarte, AC; Velasco, S; Zalba, LR1
Duarte, AI; Gonçalves, LM; Monteiro, P; Providência, LA1

Other Studies

3 other study(ies) available for adenosine diphosphate and valsartan

ArticleYear
Comparative effects of angiotensin II AT-1-type receptor antagonists in vitro on human platelet activation.
    Journal of cardiovascular pharmacology, 2000, Volume: 35, Issue:6

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Adult; Angiotensin II; Angiotensin Receptor Antagonists; Antibodies, Monoclonal; Benzimidazoles; Benzoates; Binding, Competitive; Biphenyl Compounds; Blood Platelets; Dose-Response Relationship, Drug; Humans; Imidazoles; Irbesartan; Losartan; Platelet Activation; Pyridines; Radioligand Assay; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Telmisartan; Tetrazoles; Thromboxane A2; Time Factors; Valine; Valsartan

2000
Losartan inhibits in vitro platelet activation: comparison with candesartan and valsartan.
    Journal of the renin-angiotensin-aldosterone system : JRAAS, 2000, Volume: 1, Issue:2

    Topics: Adenosine Diphosphate; Adult; Angiotensin Receptor Antagonists; Benzimidazoles; Biphenyl Compounds; Blood Platelets; Cells, Cultured; Drug Interactions; Humans; Losartan; Male; Platelet Activation; Platelet Aggregation Inhibitors; Receptor, Angiotensin, Type 1; Tetrazoles; Thromboxane A2; Valine; Valsartan

2000
Valsartan improves mitochondrial function in hearts submitted to acute ischemia.
    European journal of pharmacology, 2005, Aug-22, Volume: 518, Issue:2-3

    Topics: Acute Disease; Adenosine Diphosphate; Adenosine Triphosphate; Angiotensin II Type 1 Receptor Blockers; Animals; Heart; In Vitro Techniques; Intracellular Membranes; Membrane Potentials; Mitochondria, Heart; Myocardial Ischemia; Oxidative Phosphorylation; Oxygen Consumption; Rats; Rats, Wistar; Tetrazoles; Time Factors; Valine; Valsartan

2005